1
|
Moafi A, Zojaji A, Salehi R, Najafi Dorcheh S, Rahgozar S. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia. Cell Mol Biol (Noisy-le-grand) 2017; 63:19-22. [PMID: 28886309 DOI: 10.14715/cmb/2017.63.8.4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2017] [Revised: 05/26/2017] [Accepted: 07/13/2017] [Indexed: 11/18/2022]
Abstract
Despite advances in treatment, children with acute lymphoblastic leukemia (ALL) still experience drug resistance and relapse. Several gene mutations are involved in the onset of this disease and resistance to therapy. The present study examines the incidence of IKZF1, CDKN2A/B, PAX5, EBF1, ETV6, BTG1, RB1, JAK2, and Xp22.33 gene deletions/duplications associated with pediatric ALL in Iran and investigates the possible effect of these mutations on drug resistance. Three-year disease-free survival (3DFS) was evaluated for children diagnosed with Philadelphia negative precursor-B-cell ALL hospitalized at Sayed-al-Shohada Hospital, Isfahan-Iran, from January 2009 until December 2012. DNA was extracted from bone marrow slides, and ALL correlated gene deletions and duplications were measured using Multiplex Ligation-dependent Probe Amplification (MLPA) method. The correlation between gene mutations and 3DFS was then assessed. Among the nine aforementioned investigated genes, 63% of samples showed at least one gene mutation. At least two concomitant genomic mutations were observed in 42% of samples. Pax5 deletion was the most prevalent gene mutation observed in 45% of cases, and showed significant negative impact on response to treatment. CDKN2A/B (9p21.3) gene deletion, and ETV6 (12p13.2) gene duplication also demonstrated negative effect on patient survival and contributed to a worse prognosis if concomitant with Pax5 gene deletion. ALL patients with one of the gene deletions including Pax5 and CDKN2A/B (9p21.3) or ETV6 (12p13.2) gene duplication are classified as high-risk patients and need more intensified protocols of treatment to improve their chance of survival.
Collapse
Affiliation(s)
- A Moafi
- Department of pediatric, school of medicine, Isfahan University of medical sciences, Isfahan, Iran
| | - A Zojaji
- Department of genetics, Islamic Azad University of Tabriz, Tabriz, Iran
| | - R Salehi
- Department of Genetics, school of medicine, Isfahan University of medical sciences, Isfahan, Iran
| | - S Najafi Dorcheh
- Division of Cell and Molecular Biology, Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran
| | - S Rahgozar
- Division of Cell and Molecular Biology, Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran
| |
Collapse
|
2
|
Safavi A, Emamzadeh R, Nazari M, Ehsani M, Zarkesh-Esfahani SH, Rahgozar S. Super RLuc8-sFv; a new luciferase-labeled probe for detection of human CD4+ cells. Mol BioSyst 2017; 13:470-475. [DOI: 10.1039/c6mb00652c] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A probe has been designed, produced and assayed for the detection of T-helper cells. The sFv fragment fused to the C-terminus of super Renilla luciferase 8 (Super RLuc8) and the probe successfully used for detection of human CD4+ cells using luminometer.
Collapse
Affiliation(s)
- A. Safavi
- Department of Biology
- Faculty of Sciences
- University of Isfahan
- Isfahan
- Iran
| | - R. Emamzadeh
- Department of Biology
- Faculty of Sciences
- University of Isfahan
- Isfahan
- Iran
| | - M. Nazari
- Monoclonal Antibody Research Center
- Avicenna Research Institute
- ACECR
- Tehran
- Iran
| | - M. Ehsani
- Department of Biology
- Faculty of Sciences
- University of Isfahan
- Isfahan
- Iran
| | | | - S. Rahgozar
- Department of Biology
- Faculty of Sciences
- University of Isfahan
- Isfahan
- Iran
| |
Collapse
|
3
|
Aberuyi N, Rahgozar S, Moafi A. The role of ATP-binding cassette transporter A2 in childhood acute lymphoblastic leukemia multidrug resistance. Iran J Ped Hematol Oncol 2014; 4:118-26. [PMID: 25254091 PMCID: PMC4173032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/06/2014] [Accepted: 08/07/2014] [Indexed: 11/17/2022]
Abstract
Acute lymphoblastic leukemia (ALL) is one of the most prevalent hematologic malignancies in children. Although the cure rate of ALL has improved over the past decades, the most important reason for ALL treatment failure is multidrug resistance (MDR) phenomenon. The current study aims to explain the mechanisms involved in multidrug resistance of childhood ALL, and introduces ATP-binding cassette transporterA2 (ABCA2) as an ABC transporter gene which may have a high impact on MDR. Benefiting from articles published inreputable journals from1994 to date and experiments newly performed by our group, a comprehensive review is written about ABCA2 and its role in MDR regarding childhood ALL. ABCA2 transports drugs from the cytoplasm into the lysosomal compartment, where they may become degraded and exported from the cell. The aforementioned mechanism may contribute to MDR. It has been reported that ABCA2 may induce resistance to mitoxantrone, estrogen derivatives and estramustine. It is resistant to the aforementioned compounds. Furthermore, the overexpression ofABCA2 in methotrexate, vinblastine and/or doxorubicin treated Jurkat cells are observed in several publications. The recent study of our group showsthatthe overexpression ofABCA2 gene in children with ALL increases the risk of MDR by 15 times. ABCA2 is the second identified member of the ABCA; ABC transporters' subfamily. ABCA2 gene expression profile is suggested to be an unfavorable prognostic factor in ALL treatment. Better understanding of the MDR mechanisms and the factors involved may improve the therapeutic outcome of ALL by modifying the treatment protocols.
Collapse
Affiliation(s)
- N Aberuyi
- Division of Cell and Molecular Biology, Department of Biology, Faculty of Science, University of Isfahan, Iran
| | - S Rahgozar
- Division of Cell and Molecular Biology, Department of Biology, Faculty of Science, University of Isfahan, Iran
| | - A Moafi
- Department of Paediatric-Oncology, SayedolShohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
| |
Collapse
|
4
|
Passam FH, Rahgozar S, Qi M, Raftery MJ, Wong JWH, Tanaka K, Ioannou Y, Zhang JY, Gemmell R, Qi JC, Giannakopoulos B, Hughes WE, Hogg PJ, Krilis SA. Redox control of β2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost 2010; 8:1754-62. [PMID: 20979592 PMCID: PMC3017748 DOI: 10.1111/j.1538-7836.2010.03944.x] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2010] [Accepted: 05/28/2010] [Indexed: 12/01/2022]
Abstract
BACKGROUND β(2) -Glycoprotein I (β(2) GPI) is an abundant plasma protein that is closely linked to blood clotting, as it interacts with various protein and cellular components of the coagulation system. However, the role of β(2) GPI in thrombus formation is unknown. We have recently shown that β(2) GPI is susceptible to reduction by the thiol oxidoreductases thioredoxin-1 and protein disulfide isomerase, and that reduction of β(2) GPI can take place on the platelet surface. METHODS β(2) GPI, reduced by thioredoxin-1, was labeled with the selective sulfhydryl probe N(a)-(3-maleimidylpropionyl)biocytin and subjected to mass spectrometry to identify the specific cysteines involved in the thiol exchange reaction. Binding assays were used to examine the affinity of reduced β(2) GPI for von Willebrand factor (VWF) and the effect of reduced β2GPI on glycoprotein (GP)Ibα binding to VWF. Platelet adhesion to ristocetin-activated VWF was studied in the presence of reduced β(2) GPI. RESULTS We demonstrate that the Cys288-Cys326 disulfide in domain V of β(2) GPI is the predominant disulfide reduced by thioredoxin-1. Reduced β(2) GPI in vitro displays increased binding to VWF that is dependent on disulfide bond formation. β(2) GPI reduced by thioredoxin-1, in comparison with non-reduced β(2) GPI, leads to increased binding of GPIbα to VWF and increased platelet adhesion to activated VWF. CONCLUSIONS Given the importance of thiol oxidoreductases in thrombus formation, we provide preliminary evidence that the thiol-dependent interaction of β(2) GPI with VWF may contribute to the redox regulation of platelet adhesion.
Collapse
Affiliation(s)
- F H Passam
- Department of Immunology, Allergy and Infectious Diseases, University of New South Wales, St George Hospital, Sydney, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Morgan MD, Burke F, Biela C, Harper L, Gordon C, Young SP, Goulden BS, Turner-Stokes TJ, Pericleous C, Lambrianides A, Bell K, Ioannou Y, Latchman D, Isenberg D, Rahman A, Giles I, Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, Qi M, Yu P, Yu D, Hogg PJ, Krilis S, Haque S, Rakieh C, Salway F, Ho P, Gorodkin R, Suan Teh L, Day PJ, Bruce IN, Turner-Stokes TJ, Lu TY, Ehrenstein MR, Giles I, Rahman A, Isenberg DA, Faria RM, Chambers SA, Pegden A, Isenberg DA, Shahbaz-Samavi M, Hewitt J, Haque S, Shelmerdine J, Ahmad Y, Bruce IN, Peall A, Whyman S, Goodfellow R, Martin J, Morgan J, Rhys-Dillon C. SLE and Antiphospholipid Syndrome [223-231]: 223. Acid Disruption Biacore Analysis of Antibodies Against Rituximab in SLE Patients. Rheumatology (Oxford) 2010. [DOI: 10.1093/rheumatology/keq728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
6
|
Astorri E, Bombardieri M, Corsiero E, Gabba S, Barone F, Proctor G, Pitzalis C, Bowman SJ, St Pierre Y, Sutcliffe N, Isenberg DA, Goldblatt F, Price E, Hamburger J, Richards A, Rauz S, Regan M, Jones A, Rigby S, Mulherin D, Clarke A, Ong V, Nihtyanova S, Black C, Denton C, Barnes T, Spiller D, Anderson M, Edwards S, Moots R, Gamal M, Zaki E, Khaled HF, Abdul-Aziz OA, Shaaban AA, Abu Senna H, Bishop VL, Herrick A, Wragg E, Ioannou Y, Zhang JY, Passam FH, Rahgozar S, Qi JC, Giannakopoulos B, Qi M, Yu P, Yu DM, Hogg PJ, Krilis SA, Hopkins CW, Spiers LR, Bhagat SS, Ostor AJ, Hall FC. Concurrent Oral 10 - Connective Tissue Disease [OP65-OP72]: OP65. Molecular and Cellular Evolution of Functional Tertiary Lymphoid Structures in Salivary Glands of NOD Mice. Rheumatology (Oxford) 2010. [DOI: 10.1093/rheumatology/keq710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
7
|
Rahgozar S, Maerefat M, Mokhtari-Dizaji M. Presentation of non invasive method for estimation arterial stiffness using modeling blood flow and arterial wall based on determination of elastic modulus of arterial wall. J Biomech 2006. [DOI: 10.1016/s0021-9290(06)85533-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
8
|
Abstract
Sickle cell anemia is not considered to be a significant disease in Iran, although the sickle cell trait is estimated to have a high incidence in the Southern provinces. Since 1977, when the presence of a mild sickle cell anemia was reported in this country, there have been no further investigations published giving precise data on the incidence and origins of the sickle cell mutation in Iran. We report here the finding of patients with the sickle cell trait, sickle cell anemia, and sickle-beta thalassemia in Central Iran. A survey of 300 individuals from a village in Southeast Esfahan revealed an incidence of the sickle cell trait of 8.33%. "Cascade screening" enabled 96 relatives in four surrounding villages to be tested, and the at-risk couples were offered counseling as a "sickle cell control program." The hematological indices and HbF levels of the affected patients were determined. The HbF levels were unusually high, ranging from 18% to 41.4%, and SS patients with the highest levels were asymptomatic. Linkage analysis revealed the betaS gene haplotype in this population to be the Indian-Arab haplotype.
Collapse
Affiliation(s)
- S Rahgozar
- Department of Hematology, Tarbiat Modarres University, Tehran, Iran.
| | | | | | | |
Collapse
|